Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
Stock data | 2024 | Change |
---|---|---|
Price | $2.13 | N/A |
Market Cap | $74.85M | N/A |
Shares Outstanding | 35.17M | N/A |
Employees | 52.00 | N/A |